Dana Incorporated (DAN) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value 1.49×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | 1.49× | Operating income ÷ reported interest expense. $210.00M ÷ $141.00M ≈ 1.49× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 7.66B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 210.00M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 141.00M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $7.66B | (m) | $210.00M | $141.00M | (m) | (m) | 1.49× | Reported |
| 2026-03-31 | (m) | $7.59B | (m) | $150.00M | $164.00M | (m) | (m) | 0.91× | Reported |
| 2025-12-31 | $105.00M | $7.50B | (m) | $139.00M | $181.00M | 1.40% | (m) | 0.77× | Reported |
| 2025-09-30 | (m) | $9.96B | (m) | $362.00M | $174.00M | (m) | (m) | 2.08× | Reported |
| 2025-06-30 | (m) | $9.94B | (m) | $301.00M | $165.00M | (m) | (m) | 1.82× | Reported |
| 2025-03-31 | (m) | $9.90B | (m) | $228.00M | $161.00M | (m) | (m) | 1.42× | Reported |
| 2024-12-31 | $229.00M | $10.28B | (m) | $226.00M | $161.00M | 2.23% | (m) | 1.40× | Reported |
| 2024-09-30 | (m) | $10.44B | (m) | $273.00M | $158.00M | (m) | (m) | 1.73× | Reported |
| 2024-06-30 | (m) | $10.64B | (m) | $276.00M | $159.00M | (m) | (m) | 1.74× | Reported |
| 2024-03-31 | (m) | $10.65B | (m) | $296.00M | $159.00M | (m) | (m) | 1.86× | Reported |
| 2023-12-31 | $237.00M | $10.55B | (m) | $316.00M | $154.00M | 2.25% | (m) | 2.05× | Reported |
| 2023-09-30 | (m) | $10.62B | (m) | $367.00M | $147.00M | (m) | (m) | 2.50× | Reported |
| 2023-06-30 | (m) | $10.48B | (m) | $175.00M | $138.00M | (m) | (m) | 1.27× | Reported |
| 2023-03-31 | (m) | $10.32B | (m) | $110.00M | $131.00M | (m) | (m) | 0.84× | Reported |
| 2022-12-31 | $201.00M | $10.16B | (m) | $86.00M | $128.00M | 1.98% | (m) | 0.67× | Reported |
| 2022-09-30 | (m) | $9.87B | (m) | $104.00M | $127.00M | (m) | (m) | 0.82× | Reported |
| 2022-06-30 | (m) | $9.54B | (m) | $299.00M | $126.00M | (m) | (m) | 2.37× | Reported |
| 2022-03-31 | (m) | $9.16B | (m) | $353.00M | $128.00M | (m) | (m) | 2.76× | Reported |
| 2021-12-31 | $178.00M | $8.95B | (m) | $395.00M | $131.00M | 1.99% | (m) | 3.02× | Reported |
| 2021-09-30 | (m) | $8.78B | (m) | $415.00M | $138.00M | (m) | (m) | 3.01× | Reported |
| 2021-06-30 | (m) | $8.57B | (m) | $410.00M | $145.00M | (m) | (m) | 2.83× | Reported |
| 2021-03-31 | (m) | $7.44B | (m) | $185.00M | $143.00M | (m) | (m) | 1.29× | Reported |
| 2020-12-31 | $146.00M | $7.11B | (m) | $124.00M | $138.00M | 2.05% | (m) | 0.90× | Reported |
| 2020-09-30 | (m) | $6.99B | (m) | $134.00M | $129.00M | (m) | (m) | 1.04× | Reported |
| 2020-06-30 | (m) | $7.16B | (m) | $182.00M | $122.00M | (m) | (m) | 1.49× | Reported |
| 2020-03-31 | (m) | $8.38B | (m) | $199.00M | $124.00M | (m) | (m) | 1.60× | Reported |
| 2019-12-31 | $112.00M | $8.62B | (m) | $292.00M | $122.00M | 1.30% | (m) | 2.39× | Reported |
| 2019-09-30 | (m) | $8.61B | (m) | $302.00M | $117.00M | (m) | (m) | 2.58× | Reported |
| 2019-06-30 | (m) | $8.42B | (m) | $312.00M | $110.00M | (m) | (m) | 2.84× | Reported |
| 2019-03-31 | (m) | $8.17B | (m) | $545.00M | $99.00M | (m) | (m) | 5.51× | Reported |
| 2018-12-31 | $103.00M | $8.14B | (m) | $579.00M | $96.00M | 1.26% | (m) | 6.03× | Reported |
| 2018-09-30 | (m) | $8.01B | (m) | $551.00M | $94.00M | (m) | (m) | 5.86× | Reported |
| 2018-06-30 | (m) | $7.86B | (m) | $543.00M | $95.00M | (m) | (m) | 5.72× | Reported |
| 2018-03-31 | (m) | (m) | (m) | $535.00M | $99.00M | (m) | (m) | 5.40× | Reported |
| 2017-12-31 | $102.00M | $7.21B | (m) | $490.00M | $102.00M | 1.41% | (m) | 4.80× | Reported |
| 2017-09-30 | (m) | (m) | (m) | (m) | $108.00M | (m) | (m) | (m) | Reported |
| 2017-06-30 | (m) | (m) | (m) | (m) | $110.00M | (m) | (m) | (m) | Reported |
| 2017-03-31 | (m) | (m) | (m) | (m) | $113.00M | (m) | (m) | (m) | Reported |
| 2016-12-31 | $81.00M | $5.83B | (m) | (m) | $113.00M | 1.39% | (m) | (m) | Reported |
| 2016-09-30 | (m) | (m) | (m) | (m) | $111.00M | (m) | (m) | (m) | Reported |
| 2016-06-30 | (m) | (m) | (m) | (m) | $115.00M | (m) | (m) | (m) | Reported |
| 2016-03-31 | (m) | (m) | (m) | (m) | $112.00M | (m) | (m) | (m) | Reported |
| 2015-12-31 | $75.00M | $6.06B | (m) | (m) | $113.00M | 1.24% | (m) | (m) | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | $115.00M | (m) | (m) | (m) | Reported |
| 2015-06-30 | (m) | (m) | (m) | (m) | $114.00M | (m) | (m) | (m) | Reported |
| 2015-03-31 | (m) | (m) | (m) | (m) | $116.00M | (m) | (m) | (m) | Reported |
| 2014-12-31 | $72.00M | $6.62B | (m) | (m) | $118.00M | 1.09% | (m) | (m) | Reported |
| 2014-09-30 | (m) | (m) | (m) | (m) | $119.00M | (m) | (m) | (m) | Reported |
| 2014-06-30 | (m) | $6.69B | (m) | (m) | $116.00M | (m) | (m) | (m) | Reported |
| 2014-03-31 | (m) | $6.78B | (m) | (m) | $108.00M | (m) | (m) | (m) | Reported |
| 2013-12-31 | $64.00M | $6.77B | (m) | (m) | $99.00M | 0.95% | (m) | (m) | Reported |
| 2013-09-30 | (m) | $6.75B | (m) | (m) | $90.00M | (m) | (m) | (m) | Reported |
| 2013-06-30 | (m) | $6.80B | (m) | (m) | $85.00M | (m) | (m) | (m) | Reported |
| 2013-03-31 | (m) | $6.94B | (m) | (m) | $84.00M | (m) | (m) | (m) | Reported |
| 2012-12-31 | $57.00M | $7.22B | (m) | (m) | $84.00M | 0.79% | (m) | (m) | Reported |
| 2012-09-30 | (m) | $7.56B | (m) | (m) | $83.00M | (m) | (m) | (m) | Reported |
| 2012-06-30 | (m) | $7.79B | $13.00M | (m) | $81.00M | (m) | 0.17% | (m) | Reported |
| 2012-03-31 | (m) | $7.77B | $13.00M | (m) | $81.00M | (m) | 0.17% | (m) | Reported |
| 2011-12-31 | $52.00M | $7.59B | $8.00M | (m) | $79.00M | 0.68% | 0.11% | (m) | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $50.00M | $6.11B | $14.00M | (m) | $89.00M | 0.82% | 0.23% | (m) | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $44.00M | $5.23B | $13.00M | (m) | $139.00M | 0.84% | 0.25% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Versigent PLC (VGNT) | $3.205B | ||
| VISTEON CORP (VC) | United States | $2.398B | 16.55 |
| Dorman Products, Inc. (DORM) | United States | $3.641B | 18.26 |
| Atmus Filtration Technologies Inc. (ATMU) | United States | $3.656B | 19.39 |
| PHINIA INC. (PHIN) | United States | $2.197B | 22.60 |
| PATRICK INDUSTRIES INC (PATK) | United States | $2.176B | 20.75 |
| LCI INDUSTRIES (LCII) | United States | $2.034B | 12.21 |
| Adient plc (ADNT) | Ireland | $1.311B | 29.53 |
| Dauch Corp (DCH) | United States | $1.287B | -7.80 |
| GENTEX CORP (GNTX) | United States | $4.643B | 13.22 |